Vistagen Therapeutics, Inc. (NASDAQ:VTGN) This autumn 2025 Earnings Convention Name June 17, 2025 5:00 PM ET
Firm Members
Cynthia Lynn Anderson – VP & Chief Monetary OfficerMark Adrian McPartland – Senior Vice President of Investor RelationsShawn Ok. Singh – President, CEO & Director
Convention Name Members
Julian Pino – Stifel, Nicolaus & Firm, Integrated, Analysis DivisionLin Tsai – Jefferies LLC, Analysis DivisionMyles Robert Minter – William Blair & Firm L.L.C., Analysis Division
Operator
Good day, everybody, and thanks for standing by. Welcome to the Vistagen Therapeutics Fiscal 12 months-Finish 2025 Company Replace Convention Name and Webcast. Please notice that as we speak’s name is being recorded.
At the moment, I might like to show the decision over to your host, Mark McPartland, Senior Vice President, Investor Relations at Vistagen. Mark, please go forward.
Mark Adrian McPartland
Thanks, Victor. Good afternoon, everybody, and welcome to Vistagen’s Fiscal 12 months-end 2025 Company Replace Convention Name and Webcast. Earlier this afternoon, we issued a press launch for our fiscal year-end 2025, which ended on March 31, 2025, supplied an outline of our progress throughout our lead scientific stage neuroscience packages. We encourage you to evaluation the discharge and the 10- Ok, which could be discovered on our web site’s Traders part.
Earlier than we start, please notice that we’ll make forward-looking statements relating to our enterprise throughout as we speak’s name primarily based on present expectations and knowledge. These forward-looking statements converse solely as of as we speak, besides as regulation requires. We don’t assume any obligation to replace any forward-looking statements made as we speak or sooner or later.
After all, forward-looking statements contain dangers and uncertainties, and our precise outcomes may differ materially from these anticipated by any forward-looking statements we might make as we speak. Extra info regarding dangers and components that would have an effect on our enterprise and monetary outcomes are included in our
